When this contract comes back
estimatedThis contract runs about 48 months, so it is back on the market around August 2030.
Every contract expiring, on the radarDescription
NHS National Framework for Generics Pharmaceuticals Wave 16a
Offer reference number: CM/PHG/24/5714
Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement:
CM/PHG/24/5714/01 Oral (plus non-parenteral) products:
CESW/LSNE/NWLN: 01/02/2027 to 31/05/2030 (40 months)
CM/PHG/24/5714/02 Hospital only products:
DLN: 01/02/2027 to 31/01/2029 (24 months)
DNW: 01/02/2027 to 31/01/2029 (24 months)
CM/PHG/24/5714/03 Hospital only (housekeeping) products:
DCE/DSW: 01/02/2027 to 30/09/2027 (8 months)
DLS/DNE: 01/02/2027 to 31/05/2028 (16 months)
Official source
Source: Find a Tender Service (UK Cabinet Office / Crown Commercial Service)
Always verify details on the official notice.
Last verified against Find a Tender Service (UK Cabinet Office / Crown Commercial Service) 1 week ago
More from this buyer
Full buyer profile26 open tenders right now
- Co-producing & evaluating interventions to support MMRV uptake Somali community 1 day left
- Professional and Generic Skills Programme 5 days left
- Re-Published Medication to Manage Problematic Sexual Arousal (MMPSA) Service for the South-West, North-West and North-East regions (initial pilot service) 6 days left
Recent awards
Similar tenders
Market context
- Buyer track record on Aperlena
- 170 notices tracked · 115 awarded
- €375,853,898 in awarded contracts
Never miss a tender like this
Get an email for new tenders matching: United Kingdom. Free.
Set up my alert